SQA

DECEMBER 16, 2022

SQA Regulatory Surveillance Summary for September and October 2022. ANVISA’s Questions & Answers (Q&A) on Medical Cannabis for Clinical Investigations, 14 September 2022. ANVISA published answers to questions received during an online seminar on clinical research of medicinal cannabis held in May 2022. 30 of 2022.

FDA 40

FDA Compliance COVID-19 Licensing 40

SQA

AUGUST 8, 2023

The measure may allow the expansion of the population’s access to diagnostic procedures in the country. In August 2022, ANVISA published Resolution RDC 741/2022 , which sets the framework to consider other medical device market regulators’ authorizations. Recalls All Lots of Emerade Epinephrine Auto-Injectors (0.3

FDA 40

FDA Compliance COVID-19 World Health 40

SQA

OCTOBER 18, 2022

SQA Regulatory Surveillance Summary for July and August 2022. Counterfeit COVID-19 Antigen Rapid Test Kits Found in Ontario, 05 August 2022. Health Canada is warning consumers about counterfeit BTNX Rapid Response COVID-19 antigen rapid test kits (25-pack boxes) found in Ontario. Health Canada.

US Department of Health and Human Services 40

US Department of Health and Human Services FDA COVID-19 Compliance 40